All News

There is no code for "history of elevated PSA." There are really two questions: How does one charge for the PSA test, and how does one charge for the office visit?

This installment of Clinical Centers of Excellence series features programs offering comprehensive infertility testing, diagnosis, and treatment complemented by participation in evolving infertility and genetic research arenas.

Waiting time to nephrectomy is not a predictor of the recurrence of renal cell carcinoma.

Magnus Fall, MD, PhD, discusses the EAU guidelines and new research directions in chronic pelvic pain.

Single-payer, government-run health care: I can't wait! Twelve years of post-grad training for this?

With overall Medicare cuts of more than 21% looming by the end of February unless Congress acts, urologists are confronted with an additional 3% reduction because of new practice expense data now being used by the federal government in the formula used to set fees for urologists.

Sperm retrieval in men with nonmosaic Klinefelter's syndrome can be successful with microdissection testicular sperm extraction.

Positive results have been achieved using a novel approach for in vitro reconstitution of human kidney structures.

A newer virtual reality simulator may answer the need for an effective stand-alone system to train surgeons in robotic techniques.

Cryoablation of small renal masses-whether performed laparoscopically or percutaneously-appears to be safe and effective in patients with solitary kidneys.

Surgeon perception is not a good predictive indicator of intraoperative performance and subsequent functional outcome in robot-assisted radical prostatectomy.

It's your job to constantly seek ways to improve performance.

Urologists share their thoughts on current trends affecting their practice.

A team from Johns Hopkins University, Baltimore has developed a robotic transrectal ultrasound probe manipulator and three-dimensional reconstruction/navigation software that appear to aid in visualizing the neurovascular bundles during robot-assisted laparoscopic radical prostatectomy.

A study designed to compare prostate cancer treatment modalities between academic centers and private hospitals reveals significant disparities between the two practice settings.

Systematic reviews and abstracts for randomized controlled trials appearing in the urologic literature are generally of less than optimal quality.

Men with node-positive prostate cancer following extirpative surgery appear to benefit from immediate androgen deprivation therapy.

When a physician decides to make a change in the way they practice, regardless of whether that change is reduced hours or retirement, the ramifications need to be considered by the rest of the practice.

Men on statin therapy before radical prostatectomy had a 30% lower risk of cancer recurrence.

As physicians contemplate the impact of potentially higher taxation, it is imperative to compare investment yields or returns on an after-tax basis.

Testicular sperm extraction can be successfully performed in adolescents with Klinefelter's syndrome.

How closely do urologists follow AUA's policy statement on DVT prevention?

This list of U.S.-based clinical trials is derived from the National Institute of Health's database and includes phase III advanced prostate cancer trials that are currently recruiting participants as of Jan. 22, 2010.

Urology drugs and devices in the pipeline.

Medicare stopped paying for consults on Jan. 1. This article will provide you with our recommendations on how to bill Medicare and private payers based on the changes made by Medicare and our knowledge of payer decisions at the time the article was written.

Researchers have shown that robotic partial nephrectomy is safe and effective for renal masses larger than 4 cm.

Inflammation is highly associated with traumatic sequelae of robotic laparoscopic radical prostatectomy, but it appears that preemptive, loco-regional hypothermia to the pelvis will largely mitigate its harmful effects.

A new model has been developed to help patients with testicular cancer decide on a treatment option by assisting them in considering life expectancy and quality of life estimates as they make their choice.

An investigational treatment for premature ejaculation, PSD502, appears to delay ejaculation up to five times longer than placebo, according to a study presented at the 2009 Sexual Medicine Society of North America annual meeting in San Diego.